Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $24.9 Million - $27.4 Million
-243,542 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $348,763 - $470,867
-4,333 Reduced 1.75%
243,542 $26.1 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $319,928 - $375,490
-3,724 Reduced 1.48%
247,875 $21.7 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $2.98 Million - $3.99 Million
40,605 Added 19.24%
251,599 $24.7 Million
Q4 2019

Feb 19, 2020

BUY
$72.13 - $90.25 $25,822 - $32,309
358 Added 0.17%
210,994 $18.7 Million
Q3 2019

Nov 05, 2019

SELL
$62.98 - $75.72 $12,596 - $15,144
-200 Reduced 0.09%
210,636 $15.9 Million
Q2 2019

Aug 12, 2019

BUY
$65.7 - $83.98 $26,017 - $33,256
396 Added 0.19%
210,836 $15.3 Million
Q1 2019

May 07, 2019

SELL
$77.14 - $90.79 $125,892 - $148,169
-1,632 Reduced 0.77%
210,440 $17 Million
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $62,435 - $77,000
-802 Reduced 0.38%
212,072 $19.6 Million
Q3 2018

Nov 13, 2018

BUY
$88.91 - $98.84 $22,049 - $24,512
248 Added 0.12%
212,874 $20.1 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $846,445 - $1 Million
-9,428 Reduced 4.25%
212,626 $19.7 Million
Q1 2018

May 14, 2018

BUY
$92.01 - $123.21 $920 - $1,232
10 Added 0.0%
222,054 $21 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $67,528 - $74,050
754 Added 0.34%
222,044 $21.5 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $15.5 Million - $19.7 Million
221,290
221,290 $19.7 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $360B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mason Street Advisors, LLC Portfolio

Follow Mason Street Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mason Street Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mason Street Advisors, LLC with notifications on news.